Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of SII Pentavalent Vaccine in Vietnamese Infants
NCT03931239Completed
- Sponsor
- Vabiotech
- Start
- Mar 2018
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
- Countries
- 1
01
Overview
Open-label, single-arm trial of TritanrixHepB/Hib in diphtheria, Tetanus, pertussis and 2 more, sponsored by Vabiotech. Primary endpoint: Percent of Participants With Adverse Events Related to DTPw-HB-Hib vaccine Administration. Started Mar 2018; status: completed.
02
Drugs
TritanrixHepB/Hib
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT03931239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03931239.